Associate Professor, Medicine, Harvard Medical School, Director, Multiple Myeloma Program, Medical Oncology, Massachusetts General Hospital
My research focuses on understanding the biology of multiple myeloma and development of novel therapeutics for the treatment of myeloma. On the basic front I have been involved with understanding the role of B cell activating factor (BAFF) and cyclin d dysregulation in myeloma. I am also involved with understanding the biology of bone disease in myeloma. On the translational front, we have several interesting antibodies and small molecules including BAFF antibody and cyclin D 1 inhibitors which have been validated pre-clinically and will be translated to phase I/II clinical studies for relapsed/refractory myeloma.
years treating myeloma: 17
Number of Myeloma Patients Treated Annually: 250
Details & contact info
55 Fruit Street Downtown Crossing Beacon Hill
Boston, MA, United States, 2114
Send a message to Noopur Raje, MD